“Fights off tumors and alleviates symptoms of chemotherapy,” one vape’s advertising claims, while another is touted as an “asthma remedy, ADHD remedy, and dementia treatment.” Don’t believe the hype. Despite claims that certain vaping products may alleviate health problems, there’s no proof that they do — and they may even cause health issues, the U.S.…  read on >  read on >

Cancer patients are at risk for serious COVID-19 illness, but some are still afraid to get vaccinated against the virus, new research shows. Study authors surveyed nearly 200 high-risk cancer patients at the Mays Cancer Center in San Antonio, Texas. Only 56% said they’d received at least one COVID-19 vaccine dose, compared to the community…  read on >  read on >

U.S. operating rooms got busy once again soon after the first round of pandemic shutdowns, according to a study that challenges the widely held belief that operations have been curtailed indefinitely during the age of COVID-19. “It’s an untold story,” said senior study author Dr. Sherry Wren, a professor of general surgery at Stanford University…  read on >  read on >

Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based on the new findings, the U.S. Food and Drug Administration recently gave it…  read on >  read on >

The U.S. Food and Drug Administration on Wednesday granted emergency approval of a new antibody cocktail to prevent COVID infection in people who have weakened immune systems or who can’t tolerate COVID vaccines. “Vaccines have proven to be the best defense available against COVID-19. However, there are certain immune-compromised individuals who may not mount an…  read on >  read on >

A condition called “diabetic retinopathy” often threatens the vision of adults with diabetes, but new research suggests that kids with type 2 diabetes may be particularly vulnerable to the vision-robbing complication. In fact, these kids were nearly twice as likely to develop the condition as children with type 1 diabetes were, the researchers found. “The…  read on >  read on >